Artsiom Hramyka

ML researcher · CRUK Pathway Award PI · University of Cambridge

prof_pic.jpg

Centre for Cancer Genetic Epidemiology

University of Cambridge

Cambridge, United Kingdom

I’m a Postdoctoral Researcher and Principal Investigator at the Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, working at the intersection of machine learning and medicine. I hold a CRUK ACED Pathway Award to develop dynamic AI approaches for 5-year breast cancer risk prediction from longitudinal mammography, co-mentored by Prof. Nora Pashayan and Prof. Sue Astley, and collaborating with Prof. Fiona Gilbert’s group in the Department of Radiology.

My research focuses on cancer early detection, particularly methods for longitudinal medical imaging and Bayesian calibration of simulation models. Current and recent projects include sequence-aware vision transformers for risk-stratified breast screening, the Transformer Posterior Estimator (TPE) for amortised Bayesian calibration of cancer microsimulation models, and decoder-only GPT-style transformers for follicle distribution prediction during IVF.

I completed my PhD in Computer Science at the University of St Andrews (awarded December 2025) under the supervision of Prof. Tom Kelsey, with a thesis titled Bridging the Chasm: Improved Healthcare Using Both Established and Novel Analytical Frameworks. Before returning to academia I spent two years in industry — as a Software Engineer and then ML Engineer at ING Group in Amsterdam, and as Technical Lead at a high-growth startup.

I’m broadly interested in foundation models, generative AI, and AI for science — particularly applications where careful uncertainty quantification matters.

You can find my CV here. The best way to reach me is by email at ah2427 [at] cam.ac.uk.

news

May 01, 2026 I’ve officially started my CRUK ACED Pathway Award at the University of Cambridge — stepping into my first Principal Investigator role. Two years, £190k, building dynamic AI for 5-year breast cancer risk prediction from longitudinal mammography. :tada:
Mar 15, 2026 Returned to the University of St Andrews to guest-lecture for CS5014 (Machine Learning), covering sequence processing — RNNs, attention, and transformers. A full-circle moment.
Dec 15, 2025 Passed my PhD viva! Thesis title: Bridging the Chasm: Improved Healthcare Using Both Established and Novel Analytical Frameworks. Graduation ceremony scheduled for July 2026.
Sep 30, 2025 Spoke at the Cambridge AI in Medicine Seminar Series on Deep Learning-Based Follicle Growth Prediction using a Transformer Architecture — a decoder-only GPT-style model trained on 28k IVF/ICSI cycles.

latest posts

May 14, 2026 Welcome

selected publications

  1. JCEM
    Modelling Follicular Growth During Ovarian Stimulation Using Agent-based Artificial Intelligence
    Artsiom Hramyka, Thomas W. Kelsey, Simon Hanassab, Scott M. Nelson, Arthur C. Yeung, Sotirios Saravelos, Rehan Salim, Alexander N. Comninos, and 6 more authors
    The Journal of Clinical Endocrinology & Metabolism, 2026
  2. NatComms
    Explainable Artificial Intelligence to Identify Follicles that Optimize Clinical Outcomes During Assisted Conception
    Simon Hanassab, Scott M. Nelson, Artur Akbarov, Arthur C. Yeung, Artsiom Hramyka, Toulin Alhamwi, Rehan Salim, Alexander N. Comninos, and 5 more authors
    Nature Communications, 2025
  3. EU Focus
    Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer
    Sinan Khadhouri, Artsiom Hramyka, Kevin Gallagher, Alexander Light, Simona Ippoliti, Marie Edison, Cameron Alexander, Meghana Kulkarni, and 25 more authors
    European Urology Focus, 2024
  4. JCO GO
    Machine Learning to Predict Interim Response in Paediatric Classical Hodgkin Lymphoma Using Affordable Blood Tests
    Jennifer A. Geel, Artsiom Hramyka, Jan Plessis, Yasmin Goga, Anel Zyl, Marc G. Hendricks, Elelwani Madzhia, Vhutshilo Netshituni, and 13 more authors
    JCO Global Oncology, 2024